Cascade Bio
The University of Colorado Connection
Cascade Bio’s proprietary enzyme immobilization technology, dubbed “Body Armor,” acts as a cushion for the enzyme, enabling it to last longer, withstand more challenging conditions, and work across a wider operating window than other cell-free solutions. The technology was invented by co-founder while a graduate student in the CU Boulder laboratories of (CU Boulder Chemical and Biological Engineering) and (CU Boulder Chemical and Biological Engineering).
Funding Status and Investment Opportunities
- Industry: Biotech, Manufacturing
- Funding Stage: Seed Round
- Contact for Investment Inquiries:Alex Rosay, alex@cascadebio.com
In the News
- CU Boulder hosts showcases highlighting breakthrough innovations and investment-ready ventures (2025)
- The Colorado Office of Economic Development and International Trade announces grants to CU researchers and startups (2024, OEDIT)
- 2023 Destination Startup drives investment in intermountain west university innovations (2023)
- Cascade Biocatalysts secures $2.6M to scale enzymes for biomanufacturing (2023, Business Wire)
Venture Partners Programs
This page was last updated on Dec. 2, 2024. Please contact us for corrections or updates
The Insider Investor E-Newsletter
Media Inquiries
For marketing and communication inquiries, contact Daniel Leonard,senior marketing and communications specialist for Venture Partners at CU Boulder.
For media inquiries, please visit .